Clinical trials in Hungary – page 72

Hungary is actively involved in clinical trials focusing on various forms of cancer and blood disorders. Research encompasses non-small cell lung cancer, breast cancer, colorectal cancer, and hematologic malignancies such as multiple myeloma, acute myeloid leukemia, and lymphomas. Studies investigate novel therapies including immune checkpoint inhibitors, targeted therapies, and CAR-T cell therapy.

• Advanced and metastatic solid tumors with specific genetic mutations
• Hematologic cancers including leukemias and lymphomas
• Combination therapies and immunotherapy approaches
• Adjuvant and neoadjuvant treatment strategies

These trials aim to improve survival rates, assess treatment responses, and evaluate the safety of emerging oncological therapies in diverse patient populations.

Research in Hungary addresses cardiovascular diseases including heart failure, atherosclerotic cardiovascular disease, and hypertension. Trials also focus on type 2 diabetes mellitus, obesity, and dyslipidemia. Studies evaluate medications aimed at reducing cardiovascular events, managing blood glucose levels, and addressing lipid abnormalities.

• Heart failure with reduced or preserved ejection fraction
• Diabetes management and weight reduction therapies
• Hypercholesterolemia and hypertriglyceridemia treatment
• Prevention of stroke and myocardial infarction

The goal is to enhance patient outcomes through innovative pharmacological interventions and lifestyle modifications in cardiovascular and metabolic health.

Clinical trials in Hungary explore treatments for autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, and ankylosing spondylitis. Research includes biologic agents, JAK inhibitors, and other immunomodulatory therapies targeting inflammatory pathways.

• Moderate to severe rheumatoid arthritis and psoriatic arthritis
• Systemic lupus erythematosus and lupus nephritis
• Inflammatory myopathies and vasculitis
• Long-term safety and efficacy of biologic therapies

These studies aim to control disease activity, reduce symptoms, and improve quality of life for patients with chronic inflammatory conditions.

Hungary participates in trials for skin diseases including atopic dermatitis, psoriasis, hidradenitis suppurativa, and vitiligo. Studies assess the efficacy of topical and systemic therapies, biologics, and small molecule inhibitors in managing chronic skin conditions.

• Moderate to severe atopic dermatitis in adults and children
• Chronic plaque psoriasis and genital psoriasis
• Hidradenitis suppurativa and prurigo nodularis
• Non-segmental vitiligo

Research focuses on achieving disease control, reducing pruritus, and improving skin appearance and patient well-being.

Trials in Hungary investigate chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, and cystic fibrosis. Studies evaluate bronchodilators, anti-inflammatory agents, and antifibrotic therapies to improve lung function and reduce exacerbations.

• Moderate to severe COPD with frequent exacerbations
• Uncontrolled asthma and eosinophilic asthma
• Progressive pulmonary fibrosis and interstitial lung diseases
• Cystic fibrosis in pediatric and adult populations

The objective is to enhance respiratory function, reduce symptoms, and slow disease progression in patients with chronic lung conditions.

Research addresses inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, as well as liver diseases including non-alcoholic steatohepatitis, primary biliary cholangitis, and hepatitis B. Trials evaluate biologics, small molecules, and antiviral therapies.

• Moderately to severely active Crohn's disease and ulcerative colitis
• Non-alcoholic steatohepatitis with liver fibrosis
• Primary biliary cholangitis and primary sclerosing cholangitis
• Chronic hepatitis B and hepatitis delta infection

Studies aim to induce and maintain remission, reduce inflammation, and prevent disease progression in gastrointestinal and hepatic disorders.

Clinical trials in Hungary focus on neurological disorders including multiple sclerosis, Alzheimer's disease, Parkinson's disease, and epilepsy. Research evaluates disease-modifying therapies, symptomatic treatments, and neuroprotective agents.

• Relapsing and progressive forms of multiple sclerosis
• Mild to moderate Alzheimer's disease and cognitive impairment
• Parkinson's disease and related movement disorders
• Focal onset seizures and refractory epilepsy

The goal is to slow disease progression, manage symptoms, and improve cognitive and motor function in patients with neurological conditions.

Trials investigate chronic kidney disease, IgA nephropathy, lupus nephritis, and kidney disease-associated pruritus. Studies assess therapies aimed at preserving renal function, reducing proteinuria, and managing complications of kidney disease.

• Chronic kidney disease with and without diabetes
• IgA nephropathy and primary membranous nephropathy
• Lupus nephritis and immune-mediated kidney diseases
• Anemia and pruritus in chronic kidney disease

Research aims to delay progression to end-stage renal disease, improve patient symptoms, and enhance overall renal health.

Hungary participates in studies on retinal diseases including age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. Trials evaluate anti-VEGF therapies, intravitreal injections, and novel agents for vision preservation.

• Neovascular age-related macular degeneration
• Diabetic macular edema and diabetic retinopathy
• Geographic atrophy secondary to AMD
• Macular edema due to retinal vein occlusion

Studies focus on improving or maintaining visual acuity, reducing retinal thickness, and preventing vision loss in patients with retinal disorders.

Research in Hungary addresses bacterial and viral infections including pneumonia, urinary tract infections, COVID-19, and Clostridioides difficile infection. Trials evaluate antibiotics, antivirals, and immunoglobulins for treatment and prevention.

• Community-acquired and hospital-acquired pneumonia
• Complicated urinary tract infections and pyelonephritis
• COVID-19 and respiratory syncytial virus prevention
• Recurrent Clostridioides difficile infection

The objective is to improve clinical outcomes, reduce infection rates, and develop effective prophylactic and therapeutic strategies.

Trials focus on hemophilia, immune thrombocytopenia, paroxysmal nocturnal hemoglobinuria, and myeloproliferative neoplasms. Studies assess factor replacement therapies, immunomodulators, and targeted agents for blood disorders.

• Hemophilia A and B with and without inhibitors
• Immune thrombocytopenia and autoimmune hemolytic anemia
• Paroxysmal nocturnal hemoglobinuria
• Myelofibrosis, polycythemia vera, and essential thrombocythemia

Research aims to prevent bleeding events, improve platelet counts, and manage symptoms of hematologic conditions.

Clinical trials investigate diabetes, obesity, thyroid disorders, and osteoporosis. Studies evaluate glucose-lowering agents, weight management therapies, and bone-strengthening medications.

• Type 2 diabetes and glycemic control
• Obesity and overweight management
• Thyroid eye disease and hyperthyroidism
• Post-menopausal osteoporosis

Studies aim to optimize metabolic control, reduce body weight, and prevent fractures and complications associated with endocrine disorders.

Research in Hungary addresses major depressive disorder, schizophrenia, bipolar disorder, and Alzheimer's disease-related psychosis. Trials evaluate antidepressants, antipsychotics, and adjunctive therapies for mental health conditions.

• Major depressive disorder with anhedonia
• Treatment-resistant schizophrenia
• Bipolar disorder with mania or mixed features
• Psychosis and agitation in Alzheimer's disease

The goal is to improve mood, reduce psychotic symptoms, and enhance overall mental health and functioning in affected individuals.

Trials focus on rare genetic disorders such as Duchenne muscular dystrophy, spinal muscular atrophy, osteogenesis imperfecta, and hereditary angioedema. Studies assess gene therapies, enzyme replacement, and symptom management.

• Duchenne muscular dystrophy amenable to exon skipping
• Spinal muscular atrophy in pediatric patients
• Osteogenesis imperfecta and bone fragility
• Hereditary angioedema prevention and treatment

Research aims to slow disease progression, improve muscle function, and enhance quality of life for patients with rare genetic conditions.

Clinical trials in Hungary investigate chronic pain conditions including neuropathic pain, osteoarthritis pain, and migraine. Studies evaluate analgesics, nerve blocks, and preventive therapies for pain relief.

• Chronic pain due to diabetic peripheral neuropathy
• Knee osteoarthritis with moderate to severe pain
• Chronic and episodic migraine
• Acute pain management and postoperative analgesia

Studies aim to reduce pain intensity, improve function, and enhance patient quality of life through effective pain management strategies.